engleski

Leukopenia during therapy with risperidone long-acting injectable : two case reports

This report describes two cases of leucopenia under treatment with risperidone long-acting injectable, suggesting the necessity of early recognition of leucopenia in order to prevent occurrence of potentially life-threatening agranulocytosis.These case reports suggest the necessity of follow up of WBC count in the patients taking risperidone long-acting injectable, even after a period of treatment with risperidone tablets, in order to recognize leucopenia and prevent occurrence of potentially life-threatening agranulocytosis. Further observation is necessary for more precise understanding of this condition, particularly with respect that both of these patients were taking risperidone tablets prior to administration of risperidone long-acting injectable, with no decrease in the values of leucocytes.

leucopenia; agranulocytosis; patient; treatment

nije evidentirano